23andmeaduhelmaheadaialarmingalnylamalzheimeramgenanotherapprovalascoastrazenecabadbidenbigbiobiogenbiotechbirdblockbusterblockbustersboldboombrainbreakthroughbusinesscaliffcancercarecasecdccellceoceoschinachinesecontroversialcontroversycoronaviruscovidcrisiscrisprcurecutsdatadaydealdealmakingdebatabledebatedeepdilemmadiseasednadramadrugdrugseffectsendeveryexperimentfakefaucifdafirstfluftcfundingfuturegenegeneticgenomegeorgegetgileadglpgoldgottliebhealthhearthistoryholmeshothypeilluminaindustryinsideinsiderinsulinintriguejpmjrkidslatestlayoffslegacylegallifelillylivelonglooklossmarketmeansmedicalmedicinemerckmergermessymicrobiomemilestonemodernamrnanewsnextnihnobelnomineenovartisnovavaxnovoobesityomicronopioidpandemicpartypatientspfizerpharmapillspivotplanplansplightpluspotentialpreviewpricespricingpromisepublicquestraceredrememberingreportresearchresponsereturnreviewrfkriserisksrushsagasareptasciencescottsetbackshkrelishortagesstarstartupstartupsstatstocksstorystudysuccesssuccessionsummitsurgesurprisetakestechtestingtheranostherapiestherapytradingtreatmenttrialtrialstrumpturntwitterupheavalvaccinevaccinesvcvcsvertexweekwegovyweightwinterworldwrongyear